Work

Supplementary Figure S2 from A Phase II Study of Atezolizumab, Pertuzumab, and High-Dose Trastuzumab for Central Nervous System Metastases in Patients with HER2-Positive Breast Cancer

Year: 2024

Type: supplementary-materials

Abstract: Supplementary Figure S2. Data on bi-compartmental PFS, defined as either progression in the CNS, according to RANO-BM criteria, and/or progression in non-CNS sites, according to Response Evaluation Criteria in Solid Tumors (RECIST) 1.1.

DOI: 10.1158/1078-0432.27434407

Authors: Antonio Giordano, Priya U. Kumthekar, Qingchun Jin, Busem Binboga Kurt, Siyang Ren, Tianyu Li, Jose Pablo Leone, Elizabeth A. Mittendorf, Alyssa M. Pereslete, Laura Sharp, Raechel Davis, Molly DiLullo, Nabihah Tayob, Erica L. Mayer, Eric P. Winer, Sara M. Tolaney, Nancy U. Lin

Language: English

Topic: Brain Metastases and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4403989738

Cites:

Cited by:

Related to: 10